PBT loss widened 97% to -$810m as recap cut net debt to $50m

Operating revenue rose 8.6% to $2.7b, but the pre-tax loss widened to -$810.0m from -$411.0m (a -97.1% deterioration), and the after-tax loss expanded to -$591.0m from -$289.0m (-104.5%). Despite the worse operating outcome, the balance sheet was transformed by a recapitalisation: cash jumped to $1.8b from $266.0m, gross borrowings rose only modestly to $1.8b, and net debt collapsed to $50.0m from $1.3b. Total equity climbed 51.8% to $1.7b. Operating cash flow improved to $550.0m (+70.3%), and pre-lease free cash flow reached $223.0m, within Annolyse's historical baseline range.

Net debt fell from $1.3b to $50.0m and equity rose $572.0m, lifting cash to $1.8b. This buys runway through the pandemic recovery, but it does not change the operating reality: fuel costs and capacity restrictions widened underlying losses despite revenue recovery, and ROE deteriorated to -35.2% from -26.2%.

Revenue growth masked deep operating margin pressure. Revenue grew 8.6%, within Annolyse's historical baseline, but the PBT margin landed at -29.6%, well below the supplied baseline mean of 5.1%. Management attributes the result to high fuel prices and pandemic-related travel restrictions through to March, partially offset by record cargo revenue—useful colour, but it does not change the read that core passenger economics are still loss-making.

Inventory days are above the historical range. Inventory days reached 13.1, above Annolyse's historical baseline range of 6.9-8.9 days (mean 7.6). This is consistent with restocking ahead of capacity restoration, but it ties up working capital before the revenue benefit lands.

The interim period (HY22) reported a -$272.0m loss on $1.1b revenue, implying a second half of $1.6b revenue and a -$319.0m loss—an only marginally worse half driven by Omicron through to March. Commentary points to strong forward demand for the quarter ending July, suggesting the loss profile should narrow as international capacity returns, but this release does not quantify the recovery shape. On the supplied evidence, the recapitalisation—not a return to underlying profitability—is what carries the result.

Operating working capital moved only $6.0m during the year, against Annolyse's historical baseline of builds averaging $68.0m in the subsequent periods (none of which had a release). That means FY22 OCF was flattered by an unusually small working-capital absorption; as operations normalise and capacity returns, larger working-capital builds will compress OCF, and the FY22 conversion advantage is unlikely to repeat.

The $1.8b cash position reflects equity issuance, not earnings. Pre-lease FCF of $223.0m sits against capex that rose to $327.0m (12.0% of revenue, up from 9.2%), and FCF-to-NPAT of -37.7% reflects the underlying loss. ROE of -35.2% is below Annolyse's historical baseline range of 6.5%-19.8%. The durability of the result rests on revenue recovery and fuel-cost moderation, neither of which the current numbers prove.

This briefing cannot assess fleet-renewal commitments, fuel hedging coverage, or competitive positioning on individual international routes.